Search Ontology:
ChEBI
beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-D-Galp
- Term ID
- CHEBI:146671
- Synonyms
-
- 2-acetamido-2-deoxy-beta-D-galacto-hexopyranosyl-(1->3)-alpha-D-galacto-hexopyranosyl-(1->4)-D-galacto-hexopyranose
- 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-D-galactopyranose
- GalNAc(b1-3)Gal(a1-4)Gal
- N-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- Definition
- An amino trisaccharide consisting of 2-acetamido-β-D-galactopyranose, α-D-galactopyranose and D-galactopyranose residues joined in sequence by (1→3) and (1→4) glycosidic bonds.
- References
-
- glygen:G04014NS
- glytoucan:G04014NS
- kegg.glycan:G01300
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-D-Galp
Phenotype where environments contain beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-D-Galp
Phenotype modified by environments containing beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-D-Galp
Phenotype affecting beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-D-Galp
Human Disease Model